23.04.2024 - GAITHERSBURG, Md., April 23, 2024 (GLOBE NEWSWIRE) - Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with .